Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Cisplatin in Recurrent, Platinum Resistant and Refractory Ovarian Cancer
NCT00006028Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jan 2001
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gemcitabine, cisplatin in ovarian cancer, primary peritoneal cancer (PPC), sponsored by GOG Foundation. Started Jan 2001; status: completed.
02
Drugs
gemcitabinecisplatin
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00006028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006028.